Lamb Weston (LW) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.99%. A quarter ago, it was expected that this frozen foods supplier would post earnings of $0.54 per share when it actually produced earnings of $0.74, delivering a surprise of +37.04%.Over the last four quarters, the ...

Paychex (PAYX) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.61%. A quarter ago, it was expected that this payroll processor and human-resources services provider would post earnings of $1.21 per share when it actually produced earnings of $1.22, delivering a surprise of +0.83%.O ...

For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Five Below (FIVE) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Retail-Wholesale peers, we might be able to answer that question.Five Below is a member of the Retail-Wholesale sector. This group includes 196 individual stocks and currently holds a Zacks Sector Rank of #7. The Zacks Sector Rank includ ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Compass Therapeutics, Inc. (CMPX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Compass Therapeutics, Inc. is one of 946 individual stocks in the Medi ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks. ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tri ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sco ...

Key Points Make sure you're not totally steering clear of risk. Don't overreact to stock market turbulence. Pay close attention to the investment fees you're paying. The $23,760 Social Security bonus most retirees completely overlook › If you're someone who contributes money to an IRA or 401(k) plan each month, you should know that you're doing a great thing for your future. But saving for retirement isn't enough. It's important to invest your retirement savings so that money is able to grow ove ...

Core Viewpoint - Mangoceuticals, Inc. has successfully closed a registered direct offering and a concurrent private placement, raising approximately $2.5 million to support its health and wellness product development and operations [1][3]. Group 1: Offering Details - The transactions involved the sale of 1,930,502 Common Units, each consisting of one share of Common Stock or one Pre-Funded Warrant and one PIPE Common Warrant to purchase one share of Common Stock at an exercise price of $1.4245 [2]. - The offering price per Common Unit was set at $1.295, while the Pre-Funded Unit was priced at $1.29499, accounting for a minimal exercise price of $0.00001 per Pre-Funded Warrant [2]. - The Pre-Funded Warrants are immediately exercisable and can be exercised at any time until fully exercised [2]. Group 2: Use of Proceeds - The net proceeds from the offerings, along with existing cash, are intended for general corporate purposes and working capital [3]. Group 3: Legal and Regulatory Aspects - Aegis Capital Corp. served as the exclusive placement agent for the offerings, and the registered direct offering was conducted under an effective shelf registration statement previously filed with the SEC [4]. - The securities sold in the private placement were not registered under the Securities Act and were offered only to accredited investors [5]. Group 4: Company Overview - Mangoceuticals, Inc. focuses on developing a range of men's health and wellness products through a secure telemedicine platform, targeting areas such as erectile dysfunction, hair growth, hormone replacement therapies, and weight management [7].